Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Veradigm Inc. stock logo
MDRX
Veradigm
$4.75
-4.0%
$4.90
$3.25
▼
$5.60
$580.93M0.5114,058 shs3,026 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$6.63
-5.4%
$8.39
$4.54
▼
$15.59
$125.41M1.2353,660 shs154,059 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$6.24
-6.7%
$7.60
$3.91
▼
$8.98
$523.05M1.09361,302 shs678,238 shs
Weave Communications, Inc. stock logo
WEAV
Weave Communications
$7.42
+0.3%
$7.39
$4.24
▼
$7.70
$593.51M1.681.76 million shs1.24 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Veradigm Inc. stock logo
MDRX
Veradigm
-1.00%-0.50%+4.21%-0.40%+6.45%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-4.10%-20.97%-21.50%-9.08%-50.84%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-10.58%-15.01%-3.61%-22.77%+66.58%
Weave Communications, Inc. stock logo
WEAV
Weave Communications
0.00%0.00%+0.32%+1.63%+31.43%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Veradigm Inc. stock logo
MDRX
Veradigm
$4.75
-4.0%
$4.90
$3.25
▼
$5.60
$580.93M0.5114,058 shs3,026 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$6.63
-5.4%
$8.39
$4.54
▼
$15.59
$125.41M1.2353,660 shs154,059 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$6.24
-6.7%
$7.60
$3.91
▼
$8.98
$523.05M1.09361,302 shs678,238 shs
Weave Communications, Inc. stock logo
WEAV
Weave Communications
$7.42
+0.3%
$7.39
$4.24
▼
$7.70
$593.51M1.681.76 million shs1.24 million shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Veradigm Inc. stock logo
MDRX
Veradigm
-1.00%-0.50%+4.21%-0.40%+6.45%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
-4.10%-20.97%-21.50%-9.08%-50.84%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-10.58%-15.01%-3.61%-22.77%+66.58%
Weave Communications, Inc. stock logo
WEAV
Weave Communications
0.00%0.00%+0.32%+1.63%+31.43%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Veradigm Inc. stock logo
MDRX
Veradigm
0.00
N/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
2.56
Moderate Buy$11.2169.09% Upside
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.40
Hold$10.0060.38% Upside
Weave Communications, Inc. stock logo
WEAV
Weave Communications
2.14
Hold$7.805.14% Upside

Current Analyst Ratings Breakdown

Latest OPRX, SOPH, WEAV, and MDRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Lower Price TargetBuy$11.00 ➝ $10.00
11/12/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Reiterated RatingBuy$11.00 ➝ $10.50
11/12/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Lower Price TargetBuy$12.00 ➝ $11.00
10/27/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Reiterated RatingMarket Outperform
10/20/2026
Weave Communications, Inc. stock logo
WEAV
Weave Communications
UpgradeSell (E+) ➝ Sell (D-)
10/15/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingSell (D-)
10/12/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingBuy$14.00
10/2/2026
Weave Communications, Inc. stock logo
WEAV
Weave Communications
Reiterated RatingSell (E+)
9/29/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Boost Price TargetBuy$10.00 ➝ $11.00
8/25/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
UpgradeSell (D) ➝ Sell (D+)
8/24/2026
Weave Communications, Inc. stock logo
WEAV
Weave Communications
DowngradeOutperform ➝ Market Perform
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Veradigm Inc. stock logo
MDRX
Veradigm
$1.53B0.38N/AN/AN/A∞
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$109.43M1.15$0.89 per share7.43$7.08 per share0.94
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$77.27M6.77N/AN/A$0.82 per share7.60
Weave Communications, Inc. stock logo
WEAV
Weave Communications
$257.79M2.30$0.06 per share116.88$1.06 per share7.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/A23.25N/AN/AN/AN/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$5.13M$0.2526.5310.05N/A5.33%9.58%7.47%N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$79M-$1.09N/AN/AN/A-89.18%-128.69%-44.73%N/A
Weave Communications, Inc. stock logo
WEAV
Weave Communications
-$28.05M-$0.25N/AN/AN/A-7.97%-21.14%-8.41%N/A

Latest OPRX, SOPH, WEAV, and MDRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/11/2026Q3 2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$0.1620$0.20+$0.0380$0.06$21.19 million$21.62 million
11/3/2026Q3 2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.1980-$0.24-$0.0420-$0.24$24.03 million$24.27 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/AN/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
Weave Communications, Inc. stock logo
WEAV
Weave Communications
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Veradigm Inc. stock logo
MDRX
Veradigm
N/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
0.09
5.06
5.58
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
0.70
2.29
2.16
Weave Communications, Inc. stock logo
WEAV
Weave Communications
0.09
1.25
1.25

Institutional Ownership

CompanyInstitutional Ownership
Veradigm Inc. stock logo
MDRX
Veradigm
N/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
76.47%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%
Weave Communications, Inc. stock logo
WEAV
Weave Communications
86.83%

Insider Ownership

CompanyInsider Ownership
Veradigm Inc. stock logo
MDRX
Veradigm
2.29%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
7.50%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
Weave Communications, Inc. stock logo
WEAV
Weave Communications
16.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Veradigm Inc. stock logo
MDRX
Veradigm
2,300122.30 million105.18 millionNo Data
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
10518.91 million17.49 millionOptionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
41583.89 million79.80 millionOptionable
Weave Communications, Inc. stock logo
WEAV
Weave Communications
89080.00 million67.26 millionOptionable

Recent News About These Companies

Francisco Partners completes $650m take-private of healthcare software firm Weave
Francisco Partners Completes Acquisition of Weave
Weave Earns 2026 Great Place To Work Certification™

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Veradigm stock logo

Veradigm NASDAQ:MDRX

$4.75 -0.20 (-4.04%)
As of 01:34 PM Eastern

Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$6.67 -0.34 (-4.85%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

SOPHiA GENETICS stock logo

SOPHiA GENETICS NASDAQ:SOPH

$6.22 -0.47 (-6.96%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Weave Communications stock logo

Weave Communications NYSE:WEAV

$7.42 +0.02 (+0.26%)
Closing price 10/26/2026
Extended Trading
$7.42 0.00 (0.00%)
As of 10/26/2026 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Weave Communications, Inc. provides a customer experience and payments software platform in the United States and Canada. Its platform enables small and medium-sized healthcare businesses to maximize the value of their patient interactions and minimize the time and effort spent on manual or mundane tasks. The company's products include Unified Phone Number; Customized Phone System, a smarter phone system to identify whether incoming calls are from new or current patients, provide information at every call, and manages heavy call times; Softphones to make and receive calls from anywhere with an internet connection; Text Messaging to communicate with patients; Missed Call Text to take action in real time upon notification of a missed call; Missed Text Auto-Reply; Team Chat, a group messaging solution that helps practitioners and their staff communicate with each other from their work stations; and Weave Mobile App; It also offers Weave Reviews and Respond Assistant to request, collect, monitor, and respond to reviews; Weave Email Marketing and Email Assistant; Text Connect to interact with their existing and potential patients online directly through their websites; Weave Payments, a payment processing solution; Practice Analytics provides real-time data on patient retention, appointment scheduling, treatment acceptance rates, and revenue generation; and Call Intelligence. In addition, the company provides Digital Forms to collect patient information; Insurance Verification that provides patient insurance plan details; and Scheduling to send automatic scheduling reminders through text message. It serves customers in dental, optometry, veterinary, medical, plastic surgery, physical therapy, medical spa, and other medical specialty industries. The company was formerly known as Recall Solutions, LLC and changed its name to Weave Communications, Inc. in October 2015. Weave Communications, Inc. was founded in 2008 and is headquartered in Lehi, Utah.